There are nonpharmacological approaches to managing behavioral and psychological symptoms of dementia and the difficulties associated with evaluating and implementing these approaches.
New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.
We consult our doctors for expert medical advice, not phenomenological analysis, but perhaps a wide gulf ought not separate empirical science and research from phenomenological reflection and analysis on illness.